State revs up South City biotech engine

South City, the center of the nation’s largest biotech cluster, stands to reap the economic benefits of a state emphasis on using the industry to spur growth.

Established as the premier region in the state for biotechnology, the city and the Bay Area will be the center of state focus to generate an economic biotech engine, Lt. Gov. John Garamendi said Wednesday. Other regions include San Diego, Los Angeles-Orange County, and the Sacramento-Stockton area.

Garamendi toured Poniard Pharmaceuticals and CellGenesys Tuesday afternoon and urged the creation of a state advisory committee on biotechnology to help spur growth in California’s economy.

The committee would advise a state-level commission on economic development on how to best assuage any roadblocksforming in the biotech industry, such as a lack of qualified workers. Garamendi called the failure of California to produce qualified employees for the biotech industry a “very serious impediment” to the economic growth of the state.

In South San Francisco, 70 biotech companies are worth more than $100 billion, said Matt Gardner, the president of BayBio, a nonprofit association promoting the industry. More than $90 billion of that is associated with Genentech, he added.

The success of South City as the epicenter of biotechnology drew Poniard Pharmaceuticals from its Seattle home, said CEO Jerry McMahon, adding that the company now has access to brainpower and services not available in Seattle.

“There’s good capital here; there’s a good history here,” McMahon said.

In the Bay Area, 900 biotech companies employ 90,000 residents and are worth roughly $150 billion, and in the last year, 6,000 jobs have been created, according to a 2007 biotech industry impact report by BayBio.

But today, the “relative size of the biotech industry remains small, whether measured by total employment, total revenue or market capitalization,” according to Garamendi’s office.

Gardner said one of the roadblocks ahead is the maturation of products in the development pipeline, and while the biotechnology market has been growing 8 to 10 percent every year, “it’s going to take a tremendous effort” to see those products approved.

The average time it took the Food and Drug Administration to approve a new drug was 14 years, while the cost of developing a new drug was $800 million, according to the BayBio report.

The state could alleviate any bumps in the road biotech companies might anticipate, such as problems with manufacturing, Gardner said.

Bay Area biotech by the numbers

» 900 companies worth $150 billion

» 90,000 employees

» $6 billion in payroll

» Average wages of $68,000

» 6,000 new jobs in the last year

– Source: BayBio report

dsmith@examiner.com

Bay Area NewsLocal

If you find our journalism valuable and relevant, please consider joining our Examiner membership program.
Find out more at www.sfexaminer.com/join/

Just Posted

Gov. Gavin Newsom, show here speaking at the City College of San Francisco mass vaccination site in April, faces a recall election due to anger on the right over his handling of the pandemic, among other issues. (Kevin N. Hume/S.F. Examiner)
Why Gavin Newsom’s popularity could work against him in the recall election

Top pollster: ‘We’re not seeing the Democrats engaged in this election. And that may be a problem…’

Passengers ride the 14-Mission Muni bus on Friday, March 12, 2021. (Jordi Molina/Special to S.F. Examiner)
Transit officials fear Free Muni pilot could hurt already-strained service levels

Supporters say fare cuts could increase ridership, help low-income residents

The vacant property at 730 Stanyan St. in the Haight currently houses a safe sleeping site for the homeless. <ins>(Kevin N. Hume/S.F. Examiner)</ins>
Affordable housing project on former McDonald’s site delayed as city adds units

The start of construction on an affordable housing project on the site… Continue reading

Visitors read a notice hanging on the Polk Street entrance to City Hall on Thursday, March 26, 2020, shortly after the building was closed. (Kevin N. Hume/S.F. Examiner)
City Hall reopening to the public on June 7 after long closure due to COVID-19

San Francisco will reopen City Hall to the public on June 7… Continue reading

Historic streetcars are undergoing testing on The Embarcadero to prepare for their return to service on May 15.<ins></ins>
What to expect for Muni Metro’s relaunch on May 15

Significant service restoration includes downtown subway tunnels and historic streetcars

Most Read